Skip to main content
. 2017 Jun 15;7:3575. doi: 10.1038/s41598-017-03909-0

Figure 2.

Figure 2

Glycine treatment reduces cell loss in the ischemic brain where NMDAR channel activity and glycine receptors are inhibited. (A) Sample images of FJC strained-brain sections collected at 3 d after ischemia onset. Glycine (100 µg/100 g, icv) was administered at 3 h following I/R. At 30 min prior to glycine injection, MK-801 (8.0 µg/100 g, icv) and strychnine (1.2 µg/100 g, icv) were injected. (B) The bottom panel is a higher magnification of three regions in the upper panel marked with a frame. Bar = 100 μm. (C) Quantitative analysis of FJC-positive degenerating neurons in the ischemic brain area at 3 d after ischemia onset (n = 6, ANOVA test, *P < 0.05 vs. I/R + Stry + MK). Stry: Strychnine; Gly: glycine; MK: MK-801.